Motley Fool Premium
  1. Stocks
    2. /
  2. AstraZeneca Plc (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca Plc)

About AZN

AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca Plc (LSE: AZN) Latest News

Investing Articles

2 FTSE 100 shares to buy now in this market volatility

| Kevin Godbold

These FTSE 100 shares have been holding up well in the recent market volatility. And there are good reasons for…

Read more »

Investing Articles

Best shares to buy now: 3 UK stocks I’d snap up today

| Christopher Ruane

Our writer identifies three of the best shares to buy now for his portfolio and explains why he would consider…

Read more »

Investing Articles

UK shares I’d buy as the economy recovers 

| Manika Premsingh

With the UK economy in a pretty sweet spot and rising stock markets, what is Manika Premsingh buying?

Read more »

Investing Articles

Here’s why AstraZeneca shares are a great buy for me

| Manika Premsingh

AstraZeneca is a low-risk stock, but it has also given strong returns over time.

Read more »

Investing Articles

Pharma stock investing: Biogen vs AstraZeneca

| Kirsteen Mackay

Biogen has had its breakthrough Alzheimer's drug approved and AstraZeneca has several exciting drugs in development. Are these pharma stocks…

Read more »

Investing Articles

1 FTSE 100 and 1 FTSE 250 stock to buy

| Rupert Hargreaves

This Fool highlights one FTSE 100 and one FTSE 250 stock that he would buy for his portfolio for large…

Read more »

Investing Articles

ESG investing: should I buy these 2 UK shares?

| Christopher Ruane

As ESG investing grows, Christopher Ruane digs into the pros and cons of adding two UK shares with environmental and…

Read more »

Investing Articles

The AstraZeneca share price is climbing. Is growth really here again?

| Alan Oscroft

The AstraZeneca share price has been volatile in recent years, though we've seen a strong run since March. Will I…

Read more »

Investing Articles

4 FTSE 100 shares I’d buy in June

| Kirsteen Mackay

I've got my eye on four FTSE 100 stocks to buy and hold for five to 10 years. These are…

Read more »

Investing Articles

GlaxoSmithKline shares: why I’m not buying

| Dan Peeke

GlaxoSmithKline has been popular with investors for decades. Despite this, Dan Peeke is wary of investing in the pharmaceutical giant.

Read more »

Investing Articles

AstraZeneca stock: time to sell?

| Pam Narang

Looking beyond the company’s vaccine woes, is now the time to make the most of the uptick in AstraZeneca stock…

Read more »

Investing Articles

The AstraZeneca share price is rising fast. Here’s what I’d do now

| Manika Premsingh

The AstraZeneca share price is rising fast after its robust results. But can it rise much further from its already…

Read more »